SELP can affect the immune microenvironment of gastric cancer and is associated with poor prognosis.
The tumor microenvironment (TME) plays a crucial role in the occurrence and progression of gastric cancer.
APA
Wu Y, Liu J, et al. (2025). SELP can affect the immune microenvironment of gastric cancer and is associated with poor prognosis.. Discover oncology, 16(1), 846. https://doi.org/10.1007/s12672-025-02629-6
MLA
Wu Y, et al.. "SELP can affect the immune microenvironment of gastric cancer and is associated with poor prognosis.." Discover oncology, vol. 16, no. 1, 2025, pp. 846.
PMID
40397261
Abstract
The tumor microenvironment (TME) plays a crucial role in the occurrence and progression of gastric cancer. Yet, we still don't understand how immune and stromal components of TMEs are modulated. In this study, we applied the ESTIMATE algorithm to calculate the number of immune and stromal components in 410 STAD cases in the Cancer Genome Atlas (TCGA) database. COX regression analysis and protein-protein interaction (PPI) network construction were used to analyze differentially expressed genes (DEGs). Then, P-selectin (SELP) was identified as a predictor by cross-analysis of univariate COX and PPI. After verifying the clinical significance of SELP for study, we performed an immune infiltration analysis and identified 54 immunomodulators associated with SELP through public data. Immunomodulation associated with gastric cancer prognosis was then confirmed by LASSO regression, and the previous results were further validated with single-cell data. Finally, we verified that SELP can promote EMT on gastric cancer cells. In conclusion, we validated that SELP may affect the biological phenotype of gastric cancer with the immune microenvironment alteration of gastric cancer.
같은 제1저자의 인용 많은 논문 (5)
- Body image and acceptance of cosmetic surgery in China and the Netherlands: A qualitative study on cultural differences and similarities.
- Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study.
- PPIL1 promotes hepatocellular carcinoma progression and associates with poor prognosis.
- Curcumin for the Treatment of Inflammatory Bowel Disease: From Mechanism to Clinic.
- Correlation between Cx37 and ALK expression and prognosis of elderly patients with non-small cell lung cancer.